UNRESECTABLE ENDOMETRIAL CARCINOMA
Clinical trials for UNRESECTABLE ENDOMETRIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE ENDOMETRIAL CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets Hard-to-Treat uterine cancer
Disease control Recruiting nowThis early-stage study tests whether combining two drugs (lenvatinib and pembrolizumab) with a short course of pelvic radiation is safe and effective for people with recurrent or inoperable endometrial cancer that is mismatch repair proficient (pMMR). About 18 participants will r…
Matched conditions: UNRESECTABLE ENDOMETRIAL CARCINOMA
Phase: PHASE1 • Sponsor: Aaron Wolfson • Aim: Disease control
Last updated May 17, 2026 01:05 UTC
-
Tailor-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors. The goal is to see if this combination is safe and helps the immune system fight cancer more effectively. A…
Matched conditions: UNRESECTABLE ENDOMETRIAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:02 UTC